BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3051% above fair value
$72.63−0.16 (-0.22%)
Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%
Bio-Techne pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bio-Techne's pe ratio was 62.8× on Nov 11, 2026, against 131.7× a year earlier. Over the last 5 years it ranged from 31.0× to 136.0×, with a median of 62.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 62.8× | −57.3 |
| 2025 | Dec 31, 2025 | 120.0× | +43.4 |
| 2024 | Dec 31, 2024 | 76.6× | +25.9 |
| 2023 | Dec 29, 2023 | 50.8× | +4.5 |
| 2022 | Dec 30, 2022 | 46.3× | −73.4 |
| 2021 | Dec 31, 2021 | 119.8× | +68.9 |
| 2020 | Dec 31, 2020 | 50.8× | −41.0 |
| 2019 | Dec 31, 2019 | 91.8× | +48.4 |
| 2018 | Dec 31, 2018 | 43.5× | −23.0 |
| 2017 | Dec 29, 2017 | 66.4× | +28.2 |
| 2016 | Dec 30, 2016 | 38.2× | +6.9 |
| 2015 | Dec 31, 2015 | 31.4× | −0.6 |
| 2014 | Dec 31, 2014 | 32.0× | +1.3 |
| 2013 | Dec 31, 2013 | 30.6× | +7.7 |
| 2012 | Dec 31, 2012 | 22.9× | +0.6 |
| 2011 | Dec 30, 2011 | 22.4× | −0.1 |
| 2010 | Dec 31, 2010 | 22.5× | −2.2 |
| 2009 | Dec 31, 2009 | 24.7× | – |
See a number that looks wrong?